BHI News Section Archives - Page 56 of 1182

News

May 17, 2022

Register for Catalyze Pre-IND Webinar on May 18th @ 12 PM ET

What is a pre-IND? Why have a pre-IND? What goes into preparing for a pre-IND?…

Super User 0

Love0

BioTalk with Rich Bendis Podcast

May 16, 2022

Douglas Falk, CEO & Co-founder of Vita Therapeutics Visits BioTalk

Vita Therapeutics CEO & Co-founder Douglas Falk chats with Rich Bendis to discuss his career,…

Super User 0

Love0

News

May 16, 2022

Douglas Falk, CEO & Co-founder of Vita Therapeutics Visits BioTalk

Vita Therapeutics CEO & Co-founder Douglas Falk chats with Rich Bendis to discuss his career,…

Super User 0

Love0

News

May 16, 2022

Emergent BioSolutions to Acquire from Chimerix its Exclusive Worldwide Rights to TEMBEXA® (brincidofovir), the First FDA-Approved Smallpox Oral Antiviral for All Ages

GAITHERSBURG, Md., May 16, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today…

Super User 0

Love0

News

May 16, 2022

Emmes Supports Landmark mRNA COVID-19 Vaccine Trial in Sub-Saharan Africa

ROCKVILLE, Md., May 16, 2022 /PRNewswire/ -- Emmes, a global, full-service clinical research organization (CRO)…

Super User 0

Love0

News

May 16, 2022

The Dutch company MIMETAS expanded its license to the HUB Organoid Technology to include all organs – Drug Discovery & Development

MIMETAS, a global leader in Organ-on-a-Chip models and technology and headquartered in the Netherlands (Europe),…

Super User 0

Love0

News

May 13, 2022

IndyGeneUS AI Awarded Grant Funding through QuickFire Challenge

IndyGeneUS plans to use the grant funding from Johnson & Johnson Innovation to Scale Blockchain-secured…

Super User 0

Love0

News

May 12, 2022

Another Federal Regional Cluster Funding Opportunity Emerges

By: Brian Darmody, Chief Strategy Officer, AURP: Building Communities of Innovation May 10, 2022 Sometime…

Super User 0

Love0

News

May 12, 2022

QIAGEN Acquires Majority Stake in Enzymes Provider BLIRT S.A. | Business Wire

HILDEN, Germany & GERMANTOWN, Md.--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today…

Super User 0

Love0

BHI News Section

Register for Catalyze Pre-IND Webinar on May 18th @ 12 PM ET

Douglas Falk, CEO & Co-founder of Vita Therapeutics Visits BioTalk

Douglas Falk, CEO & Co-founder of Vita Therapeutics Visits BioTalk

Emergent BioSolutions to Acquire from Chimerix its Exclusive Worldwide Rights to TEMBEXA® (brincidofovir), the First FDA-Approved Smallpox Oral Antiviral for All Ages

Emmes Supports Landmark mRNA COVID-19 Vaccine Trial in Sub-Saharan Africa

Sponsored Deloitte: Why now could be a great time to start preparing for an IPO | Crain’s New York Business

The Dutch company MIMETAS expanded its license to the HUB Organoid Technology to include all organs – Drug Discovery & Development

IndyGeneUS AI Awarded Grant Funding through QuickFire Challenge

Another Federal Regional Cluster Funding Opportunity Emerges

QIAGEN Acquires Majority Stake in Enzymes Provider BLIRT S.A. | Business Wire

About BioHealth Innovation

Contact

Connect